Data / Drug companies / Metformin er 500 mg
Metformin er 500 mg: 11 companies and 12 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Metformin er 500 mg is listed in the FDA National Drug Code Directory by 11 companies, with 12 products in commercial distribution. 12 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet, and the newest product started marketing on June 16, 2026.
The request: Get every company that lists metformin er 500 mg in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 11
- Products
- 12
- Generic (ANDA) products
- 12 (100.0%)
- Application numbers
- 1
- Routes
- Oral
- Brand names
- Metformin
- openFDA record search
- api.fda.gov
Companies that list metformin er 500 mg
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 2 | tablet; tablet, extended release | Generic drugs (ANDA) | July 31, 2018 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | July 31, 2018 |
| Bryant Ranch Prepack | 1 | tablet, extended release | Generic drugs (ANDA) | July 31, 2018 |
| Bryant Ranch Prepack | 1 | tablet, extended release | Generic drugs (ANDA) | July 31, 2018 |
| Coupler LLC | 1 | tablet, extended release | Generic drugs (ANDA) | June 16, 2026 |
| Granules India Limited | 1 | tablet | Generic drugs (ANDA) | June 28, 2018 |
| Granules Pharmaceuticals Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | July 31, 2018 |
| Legacy Pharmaceutical Packaging, LLC | 1 | tablet, extended release | Generic drugs (ANDA) | March 10, 2022 |
| Proficient Rx LP | 1 | tablet, extended release | Generic drugs (ANDA) | July 31, 2018 |
| Quallent Pharmaceuticals Health LLC | 1 | tablet | Generic drugs (ANDA) | July 25, 2023 |
| Remedyrepack Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | June 24, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, extended release | 8 | 66.7% |
| Tablet | 4 | 33.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 12 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Biguanide | 12 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.